Loading company…
MultiplexDX develops diagnostic reagents, such as labeled oligonucleotides, mainly for breast cancer research.
Founded in 2015 and headquartered in Gaithersburg, US, MultiplexDX Inc. develops diagnostic solutions, mainly for breast cancer research. Its products include fluorescently labeled DNA and RNA oligonucleotides and custom 3'-adapters for small RNA library preparation, sold mainly to research institutions and laboratories in Germany, the United Kingdom and France. Pavol Cekan is CEO. The company raised EUR 1.20 mn on September 25, 2018, with Acorus Networks SAS and Neulogy Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in